Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment

Overview of attention for article published in Frontiers in immunology, August 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 155 Dimensions

Readers on

mendeley: 120 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 32,554 followers.

RT @FrontImmunol: New Research: Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Tr…

29 Sep 2020

Reply Repost Favourite

RT @FrontImmunol: New Research: Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Tr…

29 Sep 2020

Reply Repost Favourite

New Research: Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment: Advances in cancer immunity have promoted a major breakthrough in the field of cancer therapy. This is mainly… https://t.co/Mj

29 Sep 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.